SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-111212
Filing Date
2024-12-20
Accepted
2024-12-20 16:30:07
Documents
13
Period of Report
2024-12-18
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ea0225393-8k_citius.htm   iXBRL 8-K 22327
  Complete submission text file 0001213900-24-111212.txt   194426

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ctxr-20241218.xsd EX-101.SCH 3009
3 XBRL LABEL FILE ctxr-20241218_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE ctxr-20241218_pre.xml EX-101.PRE 22355
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0225393-8k_citius_htm.xml XML 3679
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

IRS No.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38174 | Film No.: 241568362
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)